Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Numthavaj et al, 2011, UK | 1805 patients with Bell’s Palsy aged 18 or over. | Meta-analysis of six Randomised Controlled Trials. | Overall recovery rate within 3 months | 68.9% | Different scales used to define recovery. Different levels of facial recovery used as primary end points. Small number of patients treated with antiviral alone. |
Recovery within 3 months (five studies) | Steroids plus antiviral vs steroids alone OR 1.21 (95% CI 0.77-1.89). | ||||
Recovery within 3 months (three high quality studies) | Steroids plus antiviral vs steroids alone OR 1.01 (95% CI 0.74-1.37). | ||||
Quant el al, 2009, US | 1145 patients with Bell’s Palsy – excluding children and pregnant women. | Meta-analysis of six Randomised Controlled Trials. | Overall at least partial recovery of facial muscle function | 89.7% | Different scores used to define recovery. Different levels of facial recovery used as primary end point. Varying length of follow up and time between symptoms and treatment. Dose of prednisolone used was not consistent Severity of facial muscle paralysis at presentation not consistent |
Pooled proportion patients with facial muscle recovery | Steroids 88.2% (506/754), steroids and antiviral 91.2% (521/571). | ||||
Facial muscle recovery | Steroids plus antiviral vs steroids alone OR 1.5 (95% CI 0.83-2.69), P=0.18. | ||||
de Almeida et al, 2009, Canada | 2786 patients with Bell's Palsy treated with placebo, steroids or antivirals or a combination of steroids and antivirals. | 18 trials (8 compared steroids with a control, 7 compared antivirals and steroids against a steroid control and 3 evaluated steroids and antivirals in more complicated designs). | Risk of unsatisfactory recovery >/=4 months | Regression analysis for corticosteroids plus antiviral agent OR 0.54 (95% CI 0.35-0.83), P=0.004 for the combination compared with either treatment alone. | Not all studies evaluated steroids and antiviral agents against steroids. Studies rejected by other analysts were included. Outcome defined as unsatisfactory recovery, in contrast to the other meta-analyses which used full recovery at 3 months. |
Risk of unsatisfactory recovery >/=4 months | Corticosteroid plus antiviral vs corticosteroid alone RR 0.75 (95% CI 0.56-1.00), P=0.05. | ||||
Goudakos et al, 2009, Greece | 738 patients with unilateral facial nerve weakness of no identifiable cause treated with either steroids or steroids with any antiviral agent. | Systematic review of five trials. Adequate data was available for meta-analysis from four trials. | Complete recovery at 3 months | Corticosteroids vs combined therapy OR 1.03 (95% CI 0.74-1.42), P=0.88. This was not materially affected by sensitivity analysis or sub group analyses. | Only 4 studies were used in the meta-analysis. |
Adverse events | Corticosteroids vs combined therapy OR 0.89 (95% CI 0.5-1.6), P=0.7. | ||||
Chen et al. 2005 China | 46 patients with Bell's Palsy. 23 patients received aciclovir (0.4g TDS for 5 days) and prednisolone (50mg for 5 days) and 23 received prednisolone 50mg for 5 days. Predisolone treatment was tapered over 10 days. | Randomised Controlled Trial | Full recovery of facial nerve function at 3 weeks | 12/23 (52.1%) combined treatment v 5/23 (21.7%) prednisolone only, P<0.05. | Abstract only available. |
Full recovery of facial nerve function at 4 weeks | 21/23 (91.3%) combined treatment v 18/23 (78.3%) prednisolone only, P<0.05. | ||||
Shahidullah et al, 2011, Bangladesh | 68 patients with Bell's Palsy. 34 were treated with famciclover and prednisolone and 34 with just prednisolone. | Randomised Controlled Trial | Full recovery of facial nerve function at 1 month. | 94.1% of those on combined treatment v 61.8% of those on just prednisolone. | Abstract only available. No details of drug doses or duration of treatment. |
Full recovery of facial nerve function at 3 months | 97.1% of those on combined treatment v 74.5% of those on just prednisolone. |